June 25. 2008 

Office of Pollution Prevention and Toxics (7407) 

U.S. Environmental Protection Agency 

EPA East. Room 64~8 

1200 Pennsylvania Ave .. NW 

Washington, DC 20460 

Subject: Significant New Use Notice 

Dear Sirs/Madams, 

p. 1 

S-o<&-/ 

The attached is a Significant New Use Notice (SNUN) that is being submitted in 

accordance with the requirements of the Significant New Use Rule for the substance 

regulated at 40 CFR 721.5185. That substance is 

2-Propen-1-one, 1-(4-morpho1inyl)- CASRN 5117-12-4 

It is our understanding from discussions with the Agency's Ms. Tracy Pennington that 

the Agency is preparing to publish a Federal Register (FR) Notice that would align the 

published SNUR with the underlying Modified Consent Order (MCO). The purpose of this 

SNUN is to seek the reduced regulatory requirements of the MCO prior to the pending FR 

publication of the SNUR modification as the date of this FR Notice publication is 

uncertain. 

The SNUN substance will be used by as a monomer used to manufacture a new 

polymer that is the subject of a concurrently submitted Premanufacture Notice (Pl\tfN) 

(see TSCA User Fee TS-08JB1 W). An additional purpose of this SNUN is to extend 

having to comply with the MCO requirements to customers of the new polymer 

which will contain several hundred parts per million of the unreacted SNUN substance. 

The SNUN substance was originally Pl\1N'd by 

and the MCO was subsequently assigned to 

kttcr of authorization from 

Sincerely. 

. (Sec 

and 40 CFR 721.5185 and attached 
U.S. ENVIRONMENTAL PROTECTION AGENCY 

PREMANUFACTURE 

NOTICE 

~CES 

I IIIIi: 1:111 i/!ii 11!1: fli!ill:;i W II'! II,; II!: II II J:l II, 431Jt'UUll1.10tJ~ 

nter the total numoer or pages 

in the Premanufacture Notice 

... GENERAL INSTRUCTIONS 

• You must provide all information requested in this form to the extent that it is known to or reasonably ascertainable by you. Make reasonable estimates if you do 

not have actual data. 

• Before you complete this form, you should read the "Instructions Manual for Premanufacture Notification" (the Instructions Manual is available from the Toxic 

Substances Control Act (TSCA) Information Service by calling 202-554-1404, or faxing 202-554-5603). 

I fa user fee has been remitted for this notice (40 CFR 700.45), indicate in the boxes above the TS-user fee identification number you have generated. Remember, 

your user fee ID number must also appear on your corresponding fee remittance, which is sent to EPA. HQ Accounting Operations Branch (PM-226), P.O. 

360399M. Pittsburgh, PA 15251-6399, Attn. TSCA User fee. 

Part I-GENERAL INFORMATION 

You must provide the currently correct Chemical Abstracts (CA) Name of the new 

chemical substance, even if you claim the identity as confidential. You may authorize 

another person to submit chemical identity information for you, but your submission will 

not be complete and the review will not begin until EPA receives this information. A 

letter in support of your submission should reference your TS user fee identification 

number. You must submit an original and two copies of this notice including all test data. 

If you claimed any information as confidential, a single sanitized copy must also be 

submitted. 

Part II- HUMAN EXPOSURE AND ENVIRONMENTAL RELEASE 

If there are several manufacture, processing, or use operations to be described in Part II, 

sections A and B of this notice, reproduce the sections as needed. 

Part Ill -LIST OF ATTACHMENTS 

Attach additional sheets if there is not enough space to answer a question fully. Label 

each continuation sheet with the corresponding section heading. In Part Ill, list these 

attachments, any test data or other data and any optional information included in the 

notice. 

OPTIONAL INFORMATION 

You may include any information that you want EPA to consider in evaluating the new 

substance. On page II of this form, space has been provided for you to described 

pollution prevention and recycling information you may have regarding the new 

substance. 

So-called .. binding .. boxes are included throughout this form for you to indicate your 

willingness to be bound to certain statements you make in this section, such as use, 

production volume, protective equipment . This option is intended to reduce delays 

that routinely accompany the development of consent orders or Significant New Use 

Rules. Except in the case of exemption applications (such as TMEA, L VE, LOREX) 

where certain information provided in such notification is binding on the submitter when 

the Agency approves the excmptton applicatiOn, checkmg a bmdmg box m thiS nottce 

does not by itself prohibit the submitter from later deviating from the infonnation (except 

chemical identity) reported in the form. 

CONFIDENTIALITY CLAIMS 

You mav claim anv information in this notice as confidential. To assert a claim on the 

form, m~k (X) th~ confidential box next to the information that 10u claim as 

confidential. To assert a claim in an attachment, ctrcle or brackei the information 10u 

claim as confidential. lfvou claim infonnation in the nottces as confidential you ;nust 

abo prO\ ide a 'anitized version of the mitice ltncluding attachments). For addtttonal 

mstructions on claiming mfonnation as confidential. read the Instntctions Manual. 

D Mark 1 x) 1f any mfonnatton in this not tee 1s claimed as confidential. 

EPA FORM 7710-25 (Rev 5-95) 

TEST DATA AND OTHER DATA 

You are required to submit all test data in your possession or control and to provide 

a description of all other data known to or reasonably ascertainable by you, if these 

data are related to the health and environmental effects on the manufacture, 

processing, distribution in commerce. use, or disposal of the new chemical 

substance. Standard literature citations may be submitted for data in the open 

scientific literature. Complete test data (written in English) not summaries of data 

must be submitted if they do not apoear in the ooen literature. You should clearly 

identifY whether test data is on the substance or on an analog. Also. the chemical 

composition of the tested material should be characterized. Following are 

examples of test data and other data. Data should be submitted according to the 

requirements of §720.50 of the Premanufacture Notification Rule (40 CFR Part 

720) 

Test Data (Check Below any included in this notice) 

Environmental fate data 

Health effects data 

Environmental effects data 

PhysicaUChemical Properties• 

0 Yes 

0 Yes 

0 Yes 

0 Yes 

Other data 0 Yes 

Risk assessments 

Structure/activity relationships 

Test data not in the possession 

or control of the submitter 

A physical and chemical properties worksheet is located on the last page of this form. 

TYPE OF NOTICE (Check Only One) 

0 

0 

~ 

0 

PlviN (Premanufacture Notice) r-· ~; 

c..,. __ , 

INTERMEDIATE PMN (submitted in sequence with' final product PMN) 

SNUN (Significant Ne\\ Use Notice) 

TMEA (Test Marketing Exemption Application) 

0 LYE tLow Volume Exemption):~· ~0 CFR 71J.50(Cl(:l)l 

0 LOREX (Lo\\ Release/Low Exposure Exemption) i,']l CFR 723.50(C)\2) 

0 L VE Modification 

IS THIS A CON SOLID A TED PMN? 

" of chemicals 

0 

0 

LOREX Modtficatton 

Yes 

~ (Prcnot1ce C ommuntcation ::: req111rcd. enter :: on page .l) 

Replaces previous editions of EPA Form 77 I 0-25. 

3!~6oG 
p.3 

Public reporting burden for this collection of information is estimated to average II 0 hours per response, including time for reviewing 

instructions, searching existing data sources. gathering and maintaining the data needed, and completing and reviewing the collection of 

information. Send comments regarding the burden estimate or any other aspect of this collection of information. including suggestions for 

reducing this burden, to Chief, Information Policy Branch, PM-223. U.S. Environmental Protection Agency, 401 M. St., S.W., Washington, D.C. 

20460; and to the Office of Management and Budget, Paperwork Reduction Act (2070-0012). Washington. D.C. 20503. 

CERTIFICATION 

I certify that to the best of my knowledge and belief: 

1. The company named in Part I, section A, subsection I a of this notice form intends to manufacture or import for a 

commercial purpose, other than in small quantities solely for research and development, the substance identified in Part I, 

Section B. 

2. All information provided in this notice is complete and truthful as of the date of submission. 

3. I am submitting with this notice all test data in my possession or control and a description of all other data known to or 

reasonably ascertainable by me as required by §720.50 of the Premanufacture Notification Rule. 

Additional Certification Statements: 

If you are submitting a PMN, Intermediate PMN, Consolidated PMN, or SNUN, check the following user fee certification 

statement that applies: 

[8:1 The Company named in Part I, Section A has remitted the fee of$2500 specified in 40 CFR 700.45(b), or 

D The Company named in Part I, Section A has remitted the fee of $1000 for an Intermediate PMN (defined @ 40 CFR 

700.43) in accordance with 40 CFR 700.45(b), or 

D The Company named in Part I Section A is a small business concern under 40 CFR 700.43 and has remitted a fee of $100 

in accordance with 40 CFR 700.45(b). 

If you are submitting a low volume exemption (LVE) application in accordance with 40 CFR 723.50(c)(l) or a Low release 

and low exposure exemption (LoRex) application in accordance with 40 CFR 723.50(c)(2), check the following certification 

statements: 

D The manufacturer submitting this notice intends to manufacture or import the new chemical substance for commercial 

purposes, other than in small quantities solely for research and development, under the terms of 40 CFR 723.50. 

D The manufacturer is familiar with the terms of this section and will comply with those terms; and 

D The new chemical substance for which the notice is submitted meets all applicable exemption conditions. 

D Ifthis application is for an LYE in accordance with 40 CFR 723.50(c)(l), the manufacturer intends to commence 

manufacture of the exempted substance for commercial purposes within 1 year of the date of the expiration of the 30 day 

review period. 

The accuracy of the statements you make in this notice should reOect your best prediction of the anticipated facts regarding the chemical substance 

described herein. Any knowinl! and willful misinterpretation is subiect to criminal Penaltv pursuant to 18 t;sc 1001. 

Signature and title of Authorized Official (Original Signature Requrred) Date 

Signature of agent · (if applicable) Date 

EPA FORM 7710-25 (R.:v. 5-95) Pag.: 2 

Confidential 

X 
Ia. Person 

Submitting 

Notice (in U.S.) 

b. Agent (if 

applicable) 

p.4 

Company 

City, State, Code 

Mailing address (number and street) 

Code 

c. If you are submitting this notice as part of a joint submission, mark (X) this box. ----------------------+ 

Joint Submitter (if 

applicable) 

Name official 

4. 

5. 

6. 

Contact (in 

U.S.) 

Company 

address (number and street) 

City, State, ZIP Code 

Company 

Mailing 

City, State, ZIP Code 

you (PC) concerning this notice 

and EPA assigned a PC Number to the notice, enter the number. 

you the chcrmcal 

substance covered by this notice. enter the exemption number assigned by 

EPA. If you previously submitted a PMN for this substance enter the 

PMN number assigned by EPA (i.e. withdra\\n or incomplclctctc+).---+ 

If you 

for the 

ass1 

Type of Notice- Mark (X) 

I. 

X SNl!N- Processing D Binding Option 

Mark (X) 

EPA FORM 7710-25 (Rev 5-95) 

2. 

D 

Page 3 

Import 

Only 

Mark (X) 

if none 

Mark (X) 

if none 

Mark tX) 

Binding Option 

Mark 1 

D 

3. D Both 

X 
p.5 

name of the substance based on 

conventions. 

If another person will submit chemical identity information for you (for either Item I or 2), mark (X) the box at the right. 

and address of that in a continuation sheet. 

1. Class I or 2 chemical substances (for definitions of class 1 and class 2 substances, see the Instructions Manual) 

a. Class of substance - Mark (X) I D Class I or 2 D Class 2 

b. Chemical name (Currently correct Chemical Abstracts (CA) Name that is consistent with TSCA Inventory listings for similar substances. 

For Class I substances a CA Index Name must be provided. For Class 2 substances either a CA Index Name orCA Preferred Name must 

be provided, which ever is appropriate based on CA 9CI nomenclature rules and conventions). 

2-Propen-1-one, 1-(4-morpholinyl)-

c. 

D 

information reported in this notice: (check one). 

[gl Method 2 (Other Source) 

5117-12-4 

e. For a I substance, a complete correct chemical structure diagram. For a class 2 substance- (I) List then· nm.ema1e 

precursor substances with their respective CAS Registry Numbers. (2) Describe the nature of the reaction or process. (3) Indicate the 

range of composition and the typical composition (where appropriate). (4) Provide a correct representative or partial chemical structure 

diagram. as comolete as can be known. if one can be reasonablv ascertained. 

Mark (X) this box attach a continuation sheet. 

EPA FORM 7710-25 (Rev. 5-95) Page 4 

X 

X 
p.G 

Confidential 

a. Indicate the number-average weight of the lowest molecular weight composition of the polymer you intend to manufacture. 

Indicate maximum weight percent of low molecular weight species (not including residual monomers, reactants, or solvents) below 500 and 

below 1,000 absolute molecular weight of that composition. 

Describe the methods of measurement or the basis for your estimates: GPC D Other 0: (SpecifY) 

i) lowest number average molecular weight: 

ii) maximum weight% below 500 molecular weight: 

iii) maximum weight% below 1000 molecular weight: 

You must make separate confidentiality monomer or residual information. Mark (X) the 

''Confidential" box next to any item you claim as confidential 

(I) Provide the specific chemical name and CAS Registry Number (if a number exists) of each monomer or other reactant used in the manufacture of 

the polymer. 

(2) Mark (X) this column if entry in column (I) is confidential. 

(3) Indicate the typical weight percent of each monomer or other reactant in the polymer. 

(4) Mark (X) the identity column if you want a monomer or other reactant used at two weight percent or less to be listed as part ofthe polymer 

description on the TSCA Chemical Substance Inventory. 

(5) Mark (X) this column if entries in columns (3) and (4) are confidential. 

(6) Indicate the maximum weight percent of each monomer or other reactant that may be present as a residual in the polymer as manufactured for 

commercial purposes. 

this 

% 

% 

% 

% 

•;. 

% 

c. Please identifY which method you used to develop or obtain the specified chemical identity information reported in this D Method I (CAS Inventory Expert Service- a copy of the identification report [8J Method 2 (other source) 

obtained from CAS Inventory Expert Service must be submitted as 

as attachment to this 

correct TSCA Inventory listings for similar polymers. 

e. Provide a correct representative or partial chemical structure diagram. as complete as can 

Mark (X) this box i attach a continutation sheet. 

Pa 

EPA FORM 7710-25 (Rev. 5-95) 
p. 7 

Section 8- CHEMICAL IDENTITY INFORMATION3. Impurities 

(a) IdentitY each impurity that may be reasonably anticipallxl to he pR-sent in the chemical substance as manulacturl'd for commercial purpose. Provide the 

CAS Registry Number if available. If there are unidcntitkxl impurities. cnter"'unidentifil'd ... 

Estimate the maximum of each estimate their total %. 

Maximum 

0 Mark (X) this box if you attach a continuation sheet. 

5. Trade identification- List trade names for the new chemical substance identitil'd in subsection I or 2. 

0 Mark (X) this box if you attach a continuation sheet. 

6. Generic chemical name - If you claim chemical identitY as confidential, you must provide a generic name for your substance that reveals 

the specific chemical identity of the new chemical substance to the maximum extent possible. Refer to the 

TSCA Chemical Substance Inventory, 1985 Edition, Appendix B for guidance on developing generic names. 

Mark (X) this box if attach a continuation sheet. 

percent 

% 

% 

% 

% 

% 

% 

% 

Contidential 

X 

Contidential 

7. Byproducts- Desc1ibe any byproducts resulting from the manufacture. processing. use, or substance. Provide the CAS Registry 

Number if available. 

CAS Reg Number 

EPA FORM 7710-25 (Rev. 5-95) Page6 
p.8 

Mark (X) the "Confidential" box next to any item you claim as confidential. 

1. Production volume- Estimate the maximum production volume during the first 12 months of production. Also estimate the maximum 

production volume for any consecutive 12-month period during the first three years of production. Estimates should be on 100% new chemical 

substance basis. For a Low Volume Exemption application, if you choose to have your notice reviewed at a lower production volume than 10,000 

kg!yr, specifY the volume and mark (x) in the binding box. If granted, you are bound to this volume 

Maximum first 12-month production (kglyr) Maximum 12-month production (kglyr) Conti- Binding 

(100% new chemical substance basis) (100% new chemical substance basis) dential Option 

Mark (x) 

X 

2. Use Information-- You must make separate confidentiality claims for the description of the category of use, the percent of production volume 

devoted to each category, the formulation of the new substance, and other use information. Mark (X) the ··confidential'' Box next to any item 

you claim as confidential. 

a. (I)-- Describe each intended category of use of the new chemical substance by function and application .. 

(2) -- Mark (X) this column if entry column (I) is confidential business information (CBI). 

(3) -- Indicate your willingness to have the information provided in column (I) binding. 

(4) -- Estimate the percent of total production for the first three years devoted to each category of use. 

(5) -- Mark (X) this column if entry in column (4) is confidential business information (CBI). 

(6) -- Estimate the percent of the new substance as formulated in mixtures, suspensions, emulsions, solutions, or gels as manufactured for 

commercial purposes at sites under your control associated with each category of use. 

(7) -- Mark (X) this column if entry in column (6) is confidential business information (CBI). 

(8) -- Indicate % of product volume expected for the listed ''use" sectors. Mark more than one box if appropriate. Mark (X) to indicate 

your willingness to have the use type provided in (8) binding. 

(9) -- Mark (X) this column if entry( ies) in column (8) is (are) confidential business information I CBI). 

Category of use ( l) CBI Binding Produc- CBI %in CBI % of substance expected per use CBI Option tion% Form- (8) 

(by function and application i.e. a dispersive dye Mark(x) ulation Site- Con-* Indus- Com- Binding (3) for finishing polyester fibers) (2) (4) (5) (6) (7) limited sumer trial mercia! Option j9) 

X X X X 

% % 

% Of. 

% % 

% % 

% % 

% % 

% % 

* If you have identified a "consumer" use, please provide on a continuation sheet a detailed description of the use(s) of this chemical substance in consumer products. 

In addition include estimates of the concentration ofthe new chemical substance as expected in consumer products and describe the chemical reactions by which this substance loses its identity in the consumer product. 

0Mark (X) this box if you attach a continuation sheet. 

b. Generic If you claim any category of use description in subsection 2a as confidential, enter a generic description of that category. Read the 

use Instructions Manual for examples of generic use descriptions. 

description 

Contained use in energy production .. 

D Mark (X) this box if you attach a continuation sheet. 

3. Hazard Information -- Include in the notice a copy of reasonable facsimile of any hazard \\ aming statement. label. material safety data sheet. or other Binding 

information \\hich \\ill be provided to any person who is reasonabl} likely to be exposed to this substance regarding protective equipment or practices Op1i~.o1n 

for the safe handing. transport use. or disposal of the new substance. List in part III hazard information you include. \larl (x) 

D Mark (X) this box if}OU attach hazard infom1ation. 

Part 11-- HUMAN EXPOSURE AND ENVIRONMENTAL RELEASE 

Section A-- INDUSTRIAL SITES CONTROLLED BY THE SUBMITTER Mark (X) the .. Confidential .. box next to any ih:m )OU 

EPA FORM 7710-25 (Rev. 5-95) Page 7 

• 

claim as contidential 
p.9 

Complete section A for each type manufacture. processing. or use operation the new chemical substance at industrial sites you 

control. Importers do not have to complete this section for operations outside the U.S.; however. you may still have reporting requirements if 

there are further industrial after You must describe these s. See instructions manual 

I. 

If the same operation will occur at more than one site, enter the number of sites. Identify the 

additional sites on a continuation sheet, and if any of the sites have significantly different 

production rates or operations, include all the information requested in this section for those 

sites as attachments. 

2. Continuous 

Batches/year 

Confidential 

.X 

X 

X 

d. Process description Mark (X) to indicate your willingness to have your process description binding. X 

(I) Diagram the major unit operation steps and chemical conversions. Include interim storage and transport containers (specifY- e.g. 5 gallon pails, 55 gallon 

drum, rail car. tank truck, etc.). 

(2) Provide the identity, the approximate weight (by kg/day or kg/batch on a 100% new chemical substance basis). and entry point of all starting materials and 

feedstocks (including reactants, solvents, catalysts, etc.), and of all products, recycle streams, and wastes. Include cleaning chemicals (note frequency if not 

used daily or per batch.). 

(3) Identity by number the points of release, including small or intermittent releases, to the environment of the new chemical substance. 

EPA FORM 7710-25 (Rev 5-95) Page 8 
. D.1Q 

2. Occupational Exposure-- You must make separate confidentiality claims for the description of worker activity. physical form of the new chemical substance. 

number of works exposed. and duration of activity. Mark (X} the .. Confidential" box next to any item you claim as confidential. 

(I) --Describe the activities (i.e. bag dumping, tote filling, unloading drums. sampling, cleaning. etc.) in which workers may be exposed to the substance. 

(2) --Mark (X) this column if entry in column (I) is confidential business information (CBI). 

(3} --Describe any protective equipment and engineering controls used to protect workers. 

(4) and (6) --Indicate your willingness to have the information provided in column (3) or (5) binding. 

(5) --Indicate the physical form(s) of the new chemical substance (e.g .. solid: crystal, granule. powder. or dust) and% new chemical substance (if part of a mixture) 

at the time of exposure. 

(7) --Mark (X} this column if entry in column (5) is confidential business information (CBI). 

(8) --Estimate the maximum number of workers involved in each activity for all sites combined. 

(9} --Mark (X) this column if entry in column (8) is confidential business information (CBI). 

(I 0) and (II)-- Estimate the maximum duration of the activity for any worker in hours per day and days per year. 

( 12) -- Mark (X) this column if entries in columns (I 0) and (II) are confidential business information (CBI). 

Worker activity CBI Protective Equipment/ Binding Physical forms( s) Binding CBI #of CBI Maximu duration CBI 

m 

(i.e .. bag dumping, filling drums) Engineering Controls Option and 0

/0 new Option Workers Hrs/day Days/yr Mark(x) substance Mark(x) Exposed 

(I) (2) (3) (4) (5) (6) (7) (8) (9) (10) (II) (12) 

X 

[ ] Mark (X) this box if you attach a continuation sheet. 

3. Environmental Release and Disposal-- You must make separate confidentiality claims for the release number and the amount of the new chemical substance 

released and other release and disposal information. Mark (X) the ··confidential" box next to each item you claim as confidential. 

(I) --Enter the number of each release point identified in the process description, part II, section A, subsection I d(3). 

(2) --Estimate the amount of the new substance released (a) directly to the environment or (b) into control technology (in kg/day or kg/batch). 

(3) --Mark (X) this column if entries in columns (I) and (2) are confidential business information (CBI). 

(4) --Identify the media (stack air, fugitive air (optional-see Instruction Manual). surface water, on-site or off-site land or incineration, POTW, or other (specify)) to 

which the new substance will be released from that release point. 

(5) --a. Describe control technology, if any, and control efficiency that will be used to limit the release of the new substance to the environment. For releases 

disposed of on land, characterize the disposal method and state whether it is approved for disposal of RCRA hazardous waste. On a continuation sheet, for 

each site describe any additional disposal methods that will be used and whether the waste is subject to secondary or tertiary on-site treatment. b. Estimate 

the amount released to the environment after control technology (in kg/day). 

(6) --Mark (X) this column if entries in columns (4) and (5) are confidential business information (CBI). 

(7) --Identify the destination(s) of releases to water. Please supply NPDES (National Pollutant Discharge Elimination System) numbers for direct discharges or 

NPDES numbers of the POTW (Publici Owned Treatment Works). Mark (X) if the POTW name or NPDES #is confidential business information (CBI). 

Release Amount of new substance CBI Media of Control technology and efficiency (you may wish to optionally attach efficiency data) CBI 

Number released release 

(I) (2a) (2b) c g. stackaar Binding 

(3) (4) (Sa) Mark(X) (5b) (6) 

X 

(7) Mark (X) the D POTW provide name(s) below: CBI [] Navigable D Other- Specify provide NPDES # CBI 

dcstination(s) of r--x- waterway X releases to water. 

J Mark (X) this box if you attach a continuation sheet. 

EPA FOR~ 7710-25 (Rev 5-95) Page 9 
p. 11 

Part 11-- HUMAN EXPOSURE AND ENVIRONMENTAL RELEASE-- Continued 

Section B -- INDUSTRIAL SITES CONTROLLED BY OTHERS 

Complete section B for typical processing or use operations involving the new chemical substance at sites you do not control. Importers do not have to complete this 

section for operations outside the U.S.; however, you must report any processing or use activities after import. See the Instructions Manual. Complete a separate 

section B for each type of processing. or use operation involving the new chemical substance. If the same operation is performed at more than one site describe the 

typical operation common to these sites. Identifv additional sites on a continuation sheet. 

1. Operation Description --To claim information in this section as confidential, circle or bracket the specific information that you claim as confidential. 

(I)-- Diagram the major unit operation steps and chemical conversions. including interim storage and transport containers (specify- e.g. 5 gallon pails. 55 gallon 

drums. rail cars, tank trucks. etc). On the diagram. identify by letter and briefly describe each worker activity. (2) --Provide the identity, the approximate weight 

(by kg/day or kg/batch, on an I 00% new chemical substance basis), and entry point of all feedstocks (including reactants, solvents and catalysts, etc) and all 

products. recycle streams, and wastes. Include cleaning chemicals (note frequency if not used daily or per batch). (3) -- IdentifY by number the points of release, 

including small or intermittent releases, to the environment of the new chemical substance. (4) Please enter the# of sites (remember to identifY the locations of 

these sites on a continuation sheet): 

#of sites 

[X] CBI 

D Mark (X) this box if you attach a continuation sheet. 

2. Worker Exposure/Environmental Release 

(I) --From the diagram above, provide the letter for each worker activity. Complete 2-8 for each worker activity described. 

(2) --Estimate the number of workers exposed for all sites combined. 

(4) --Estimate the typical duration of exposure per worker in (a) hours per day and (b) days per year. 

(6) --Describe physical form of exposure and% new chemical substance (if in mixture), and any protective equipment and engineering controls. if any, used to 

protect workers. 

(7) --Estimate the percent of the new substance as formulated when packaged or used as a final product. 

(9) --From the process diagram above, enter the number of each release point. Complete 9-13 for each release point identified. 

(I 0) -- Estimate the amount of the new substance released (a) directly to the environment or (b) into control technology to the environment (in kg/day or kg/batch). 

(12) --Describe media of release i.e. stack air, fugitive air (optional-see Instructions Manual), surface water, on-site or off-site land or incineration, POTW, or other 

(specify) and control technology, if any, that will be used to limit the release of the new substance to the environment. 

(14) --Identify byproducts which may result from the operation. 

(3}, (5), (8). (I 1), (13) and (15) --Mark (X) this column if any of the proceeding entries are confidential business information (CBO. 

Letter #of CBI Duration CBI Protective Equip. I ~~in CBI Release Amount of CBI Media of Release CBI 

of Workers of Engineering Controls/ Fonn- Number New & Control 

Act- Exposed Exposure Physical Form and % ulation Substance Technology 

ivity new substance Released 

(I) (2) (J) (4a) (4b) (5) (6) (7) (8) (9) (lOa) (JOb) (II) (12) (13) 

X 

14) -- Byproducts: (15) 

D Mark (X) this box if)OU attach a continuation sheet. 

EPA fORM 7710-25 (R.:v. 5-95) Page 10 
p.12 

OPTIONAL POLLUTION PREVENTION INFORMATION 

To claim information in this section as confidential circle or bracket the specific information that you claim as confidential. 

In this section you may provide information not reported elsewhere in this form regarding your efforts to reduce 

or minimize potential risks associated with activities surrounding manufacturing, processing, use and disposal 

of the PMN substance. Please include new information pertinent to pollution prevention, including source 

reduction, recycling activities and safer processes or products available due to the new chemical substance. 

Source reduction includes the reduction in the amount or toxicity of chemical wastes by technological 

modification, process and procedure modification, product reformulation, raw materials substitution, and/or 

inventory control. Recycling refers to the reclamation of useful chemical components from wastes that would 

otherwise be treated or released as air emissions or water discharges, or land disposal. Descriptions of pollution 

prevention, source reduction and recycling should emphasize potential risk reduction subsequent to compliance 

with existing regulatory requirements and can be either quantitative or qualitative. The EPA is interested in the 

information to assess overall net reductions in toxicity or environmental releases and exposures, not the shifting 

of risks to other environmental media or non-environmental areas (e.g., occupational or consumer exposure). In 

addition, information on the relative cost or performance characteristics of the PMN substance to potential 

alternatives may be provided. 

All information provided in this section will be taken into consideration during the review of this 

substance. See Instructions Manual and Pollution Prevention Guidance manual for guidance and 

examples. 

Describe the expected net benefits, such as (I) an overall reduction in risk to human health or the environment; (2) a reduction in the 

volume manufactured; (3) a reduction in the generation of waste materials through recycling, source reduction or other means; (4) a 

reduction in potential toxicity or human exposure and/or environmental release; (5) an increase in product performance, a decrease in 

the cost of production and/or improved operation efficiency of the new chemical substance in comparison to existing chemical 

substances used in similar application; or (6) the extent to which the new chemical substance may be a substitute for an existing 

substance that poses a greater overall risk to human health or the environment. 

D Mark (X) this box if you attach a continuation sheet. 

EPA FORM 7710-25 (R.:v 5-95) Page II 
p.13 

Part III-- LIST OF ATTACHMENTS 

Attach continuation sheets for sections of the fonn and test data and other data (including physical/chemical properties and 

structure/activity information), and optional infonnation after this page. Clearly identify the attachment and the section of the fonn to 

which it relates, if appropriate. Number consecutively the pages of the attachments. In the column below, enter the inclusive page 

numbers of each attachment. 

Mark (X) the '·Confidential"' box next to any attachment name you claim as confidential. Read the Instructions Manual for guidance on 

how to claim any information in an attachment as confidential. You must include with the sanitized copy of the notice form a sanitized 

version of any attachment in which you claim information as confidential. 

Attachment name Attachment Contipage number(s) dential 

Material Safetv Data Sheet (MSDS) 

Letter of Authorization 14 

[ ] Mark (X) this box if you attach a continuation sheet. Enter the attachment name and number. 

EPA FORM 7710-25 (Rev 5-95) Page 12 
p.14 

PHYSICAL AND CHEMICAL PROPERTIES WORKSHEET 

To assist EPA ·s review of physical and chemical properties data. please complete the following worksheet for data you provide and include it in the notice. IdentifY the property measured. the page of the notice on which the property appears. the value of the property. the units in which the property is measured (as necessary), and whether or not the property is claimed as confidential. The physical state of the neat substance should be provided. These measured properties should be for the neat (I 00% pure) chemical substance. Properties that are measured for mixtures or formulations should be so noted (% PMN substance in _). You are not required to submit this worksheet; however, EPA strongly recommends that you do so. as it will simplifY review and ensure that confidential information is properly protected. You should submit this worksheet as a supplement to your submission of test data. This worksheet is not a substitute for submission of test data. 

Property 

(a) 

Physical state of neat substance 

Vapor pressure 

@Temperature oc 

Density/relative density 

Solubility 

@ Temperature oc 

Solvent 

Solubility in water@ Temperature oc 

Melting temperature 

Boiling I sublimation temperature@ torr pressure 

Spectra 

Dissociation constant 

Particle size distribution 

Octanol I water partit.ion coefficient 

Henry's Law constant 

Volitalization from water 

Volitalization from soil 

_l)_H@_ concentration 

Flammability 

ExQiodability_ 

Adsorption I coefficient 

Other - Specify 

Mark Page Value 

(X) if number 

provided (b) (c) 

(s) (I) (g) 

Torr 

glcm3 

giL 

giL 

oc 

oc 

Measured o Conti· 

Estimate dential 

Mark(X) 

(MorE) (d) 

ATTACHMENT 

PAGE 13 
.. II ' .. 

. . 

U.S. Environmental Protection Agency 

New Chemicals Branch 

OPPT Document Control Office(7407M) 

1200 Pennsylvania A venue 

Washington, D.C. 20460 

Dear Ladies and Gentlemen: 

June 19, 2008 

has advised us that it intends to submit a significant new use notice (SNUN) for . 

p.15 

which is the subject of Premanufacture Notice (PMN) , a Consent 

Order etTective December 4, 1998, a significant new use rule (SNUR) at , and a 

Modified Consent Order dated October 18, 2002. We understand that a revised SNUR reflecting 

the Modified Consent Order is being prepared, but has not yet been published. 

The original PMN was submitted by our affiliate, 

, . which also was a party to the original Consent Order. assigned the Consent Order 

to us and we submitted the assignment to Lorraine Passe of the EPA's New Chemicals Branch 

by letter dated June 1, 2004. 

We hereby authorize the EPA to reference all information submitted in connection with 

PMN , including information submitted to obtain the Modified Consent Order, in the 

EPA's review of the SNUN to be submitted by Some of the information 

submitted in support of the PMN was confidential business information (CBI). The CBI should 

be used and referenced only by the EPA. 

Sincerely, 

Department ~tanager 

An affiliate of 
92b12757385 

p.16 

06:25:34 a.m. 07-24-2008 16/29 

July 24, 2008 

COMPAf.RI . 

Ms. Tracey Pennington, Program Manager ,., ' SANITIZED 

Office of Pollution Prevention and Toxics (7405M) 

U.S. Environmental Protection Agency 

Fax#: 202-564-9490 

Subject: SNUN S-08-0007 (TSCA User Fee TS-08JB2W) 

Dear Ms. Pennington, 

-

As you requested of me yesterday afternoon, accompanying this fax please find the 

current MSDS (sanitized and un-sanitized) for this SNUN substance from the supplier we 

will be purchasing from once this SNUN and PMN review periods expire and we are able to 

commence commercial manufacture of the PMN substance P-08-0501 which uses this SNlJN 

substance. I am also including revised PMN pages 1 and 12 for the sanitized and un-sanitzed 

versions of this SNUN to show the increase in the number of pages in the SNUN and showing 

this MSDS as an attachment to the SNUN. 

If I can be of any further assistance please feel free to call me directly at 281-275-74 71 or 

e-mail me at michael.curl@bakerpetrolite.com. 

Sincerely, 

II~'JP~~~J~P,I!~~~ ~o<g- oo1 
92812757385 06.25.42 a.m. 07-24-2008 

p.17 17/29 

U.S. ENVIRONMENTAL PROTECTION AGENCY 

EPA PREMANUFACTURE 

NOTICE 

GENERAL INSTRUCTIONS 

You must provide all infonnation requested in this form to the extent that it is known to or reasonably ascertainable by you. Make reasonable estimates not have actual data. 

Before . ... ~· you complete this fonn, you should read the "Instructions Manual for Premanufacture Notification" (the Instructions Manual is available from the Toxic Substances Control Act (TSCA) Infonnation Service by calling 202-554-1404, or fux.ing 202-554-5603). -

If a user fee has been remitted for this notice (40 CFR 700.45), indicate in the boxes above the TS-user fee identification number you have generated. Rcmembet, your user fee ID number must also appear on your corresponding fee remittance, ~ich is sent to EPA, HQ Accounting Operations Branch {PM-226), P.O. 360399M, Pittsburgh, PA 15251-6399, Attn. TSCA User fee. 

Part I-GENERAL INFORMATION 

Y oo must provide the currently COITeCt Chemical Abstracts (CA) Name of the new 

chemical substance, even if you claim the identity as confidential. You may authorile 

another person to submit chemical identity information for you, but your submission will 

not be complete and the review will not begin until EPA receives this information. A 

letter in support of your submission should reference your TS user fcc identification 

number. You must submit an original and two copies of this notice including alltCSI data. 

If you claimed any information as confidential. a single sanitized copy must also be 

submitted. 

Part D- HUMAN EXPOSURE AND ENVIRONMENTAL RELEASE 

If there arc several manufacture, processing, or usc operations to be described in Part II, sections A and B of this notice, reproduce the sections as needed. 

Part III-LIST OF ATTACHMENTS 

Attach additional sheets if there is not enough space to answer a question fully. Label 

each continuation sbeet with the c<XTCSponding section heading. In Part III, list these 

attachments, any test data or other data and any optional information included in the 

notice. 

OPTIONAL INFORMATION 

You may include any info110ation that you want EPA to consider in evaluating the new 

substance. On page II of this form, space has been provided for you to described 

pollution prevention and recycling information you may have regarding the new 

substance. 

So-called "binding" boxes are included throughout this form for you to indicate your 

willingness to be bound to certain statements you make in this section, such as use, 

production volume. protective equipment . . . This option is intended to reduce delays 

that routinely accompany the development of consent orders or Significant New Use 

Rules. Except in the case of exemption applications (such as TMEA, L VE, LOREX) 

where certain info11nation provided in such notification is binding on the subminer when 

the Agency approves the exemption application, checking a binding box in this notice 

~by itself prohibit the subminer from later deviating from the infonnation (e~cept 

chemical identity) reported in the form. 

CONFIDENTIALITY CLAIMS 

You may claim any information in this notice as confidential. To assert a claim on the 

form, mark (X) the confidential box next to the info110ation that you claim as 

confidential. To assert a claim in an attachment, circle or bracket the information you 

claim as confidential. Jfvou claim info11nation in tbe ootices as conli!lentia! yoo must 

also provide a sanitized ymion of the notjce Cineluding attachments>. For additional 

instructions on claiming information as confidential, read the Instructions Manual. 

0 Mark (x) if any information in this notice is claimed as confidential. 

EPA FORM 7710-25 (Rev. 5-95) 

TEST DATA AND OTHER DATA 

You are required to submit all test data in your possession or control and to provide 

a description of all other data known to or reasonably ascertainable by you, if these data are related 10 the health and environmental effects on the manufacture, 

processing, distribution in commerce, use, or disposal of the new chemical 

substance. Standard literature citations may be submitted for data in the open 

scientific literature. Complete test data (written in English) not swnmaries of data. 

must be SUbmitted ifthev do not appear in the open lilerature. You should clearly 

identitY whether test data is on the substance or on an analog. Also, the chemical 

composition ofthe tested material should be characterized. Following arc 

examples of test data and other data. Data should he submitted according to the 

requirements of §720.50 of the Premanulilcture Notification Rule (40 CFR Part 

720) 

Test Data (Check Below any included in this notice) 

Environmental fate data 

Health effects data 

Environmental effects data 

0 Yes 

0 Yes 

D Yes 

PhysicaVCbemical Properties• D Yes 

Other data D Yes 

Risk assessments 

Structure/activity relationships 

TCSI data not in the possession 

or control of the submitter 

• A physical and chemical properties worksheet is located on the last page of this form. 

TYPE OF NOTICE (Check Only One) 

D 

D 

~ 

D 

PMN (!'remanufacture Notice) 

INTERMEDIATE PMN (sub mined in sequence with final product PMN) 

SNUN (Significant New Use Notice) 

TMEA (Test Marketing Exemption Application) 

0 LVE(Low Volume Exemption)@ 40CFR 723.50(c)(l) 

0 LOREX (Low Release/Low Exposure Exemption)@ 40 CFR 723.50(c)(2) 

D L VE Modification 

IS TIUS A CON SOLID A TED PMN? 

# of chemicals 

D 

D 

LOREX Modification 

Yes 

(Prenotice Communication #required, enter# on page 3) 

Replaces previous editions of EPA Fonn 1710-25. 
p.18 

92tl12757385 06:26:08 a.m. 07-24-2008 18/29 

Part III-- LIST OF ATTACHMENTS 

Attach continuation sheets for sections of the fonn and test data and other data (including physical/chemical propenies and 

structure/activity infonnation), and optional infonnation after this page. Clearly identify the attachment and the section of the fonn to 

which it relates, if appropriate. Number consecutively the pages of the attachments. In the column below, enter the inclusive page 

numbers of each attachment. 

Mark (X) the "Confidential" box next to any attachment name you claim as confidential. Read the Instructions Manual for guidance on 

how to claim any infonnation in an attachment as confidential. You must include with the sanitized copy of the notice fonn a sanitized 

version of any attachment in which you claim infonnation as confidential. 

Attachment name Attachment Conti· ~enumbe~} dential 

15-25 

Material Safetv Data Sheet lMSDS) 

Letter of Authorization 14 

j ] Mark (X) lhis box if you attach a continuation sheet. Enter lhe attachment name and number. 

EPA FORM 7710-25 (Rev. 5-95) Page 12 
92ll12757385 

·-._. 

p.19 06:2617am. 07-24-2008 19/29 

Supplier and Prep.-ar of thia MS D S : 

Telephone 

Fax 

Acryloxl Morpho I ina· Material Safety Data Sheet 

Section 1: Chamic11 Product and Company Identification 

Identity Acrytoyl Morpholine (A CMO) 

Popular Name ACMO 

Chemical Name Morpholine~4·(1-oxo--2-propenyl)· 

Chemical Formula C 7 H 11 NO, 

c A s (Chemical Abstract 5117-12-4 

Service)Number 

Manufacturer's Name 

Manufacturer's Address 

Emergency Telephone 1-800-424-9300( C H EM T R E C, u. s. A. ) 

Number 

Information Telephone -· 

Number .. 

. . . 

Date Prepared September 21 I 2006 

Section 2: Hazardous Ingredients/Identity Information 

Component: ACMO does not contain other hazardous ingredients. 

Page 1 of 1 1 

September 21 1 2006 

Acryloyl Morpholine 
9~12757385 

.._, 

.._. 

.......... 

06 26:25 a.m. 07-24-2008 

Section 3· Haz•dous /Identification 

Appearance 

Routes of Exposure 

Perm luible Exposure 

Limits 

Target Organs 

Signs and Symptoms of 

Exposure 

Medical conditions 

generally known to be 

aggravated by exposure 

to the material 

Health Hazards 

Carcinogenicity 

Clear and low odor liquid. 

inhalation, contact With skin or eyes, ingestion 

OSHA Permissible Exposure limit: None established 

ACGIH ThreShold limit Value: None established 

Skin, eyes, mucous membranes, liver, respiratory system 

Eye irritation 

The inhalation of high vapor concentration may cause a headache 

And nausea. 

No applicable information found. 

Acute oral toxicity LD110= 588mg/kg(rats) 

Acute dermal toxicity LD I o= No leas than 2.0g/kg(rata) 

Acute inhalation toxicity LC110= No less than 5.28 mgll 

(rats, 1 and 4 hour) 

13-week Oral toxicity [OECD 408) NOEL=20mglkg/day(rats) 

Reproduction/developmental toxicity screening test (OECD 422) 

NOEL::75mg/kg/day(rats) 

Neurotoxicity screening battery [EPA OPPTS 870.6200] 

NOEL::75mglkg/day(rats) 

13-week Inhalation toxicity [OECD 413) 

NOEL<0.0124mg/Uday(rata) 

Primary Irritation lndex(PII)= 0.5 

Mutageniclty{Bacteriologlcal test): negative 

Mouse micronucleus test(Non-bacteriologlcal test In vivo):negative 

NOTE: ACMO Is a new Chemical substance that has not yet been fully 

tested according to the EPA regulations under the Toxic Substances 

Control Act. Therefore user should assume that ACMO may cause 

internal organ effects, reproductive effects. 

National Toxicology Program(N T P):Not listed 

NT P Annual Report on Carcinogens, 7th Ed.:Not listed 

International Agency for Research on Cancer, Monographs: No 

OSHA Regulated(29 C.F.R 11910 Subpart Z):No 

liD 

Page2 of 1 1 

September 21 , 2006 

Acryloyl Morpholine 

p. 29ot29 
92"812757385 

p.21 06:26 39 a.m. 07-24-2008 21 /29 

Section 4" First Aid Measures 

Emergency and First Ald 

Procedures 

Eye Contact 

Skin Contact: 

I ngeation(swallowed): 

Inhalation: 

CALL A POISON CENTER OR A PHYSICIAN 

IMMEDIATELY 

If a knoWn exposure occurs or If a poisoning is suspected, do not 

wait for symptoms to develop. 

Immediately start the recommended procedures below and simultaneous 

ly contact a poison center, a physician, and/or the nearest hospital. 

Inform the person contacted of the extent of exposure, describe 

the victim's symptoms and follow the advice given. 

Immediately wash eyes with running water for 15 minutes. 

Consult a physician. Do not apply oil or oily ointments unless 

ordered by a physiCian. 

Immediately wash skin with plenty of water. Remove contaminated 

clothes. If irritation develops, consult a physician. 

Dilute with water by giving glasses of water to the victim, then induce 

vomiting by sticking finger down the victim's throat 

Do not make an unconscious person vomit Get medical attention 

Immediately. 

Remove the victim to fresh air. Get medical attention immediately. 

If the victim Is not breathing, clear victim's airway and start 

mouth-to-mouth artificial respiration, which may be supplemented 

by the use of a bag-mask or other N J 0 S H approved respirator or 

manually triggered oxygen supply capable of delivering one liter per 

second or more. 

If the victim Is breathing, supplemental oxygen may be given from 

a demand-type or continuous-flow inhaler, preferably with a physician's 

advice. 

ll 

Page 3 of 1 1 

September 21 . 2006 

Acryloyl Morpholine 
92'812757385 06.26.50 a.m. 07-24-2008 

Section 5· Fire and Explosion Hazard Data 

Flash Point 250.7'F, 126.5'C (using the Pensky-Martens Closed Tester method) 

Flammable Limits Lowest Limit (Q80'C, 200Torr): 2.5% 

Highest Limit (@100'C, 200Torr): 25.0% 

Extinguishing Media water spray, dry chemical powder, carbon dioxide, foam 

Special Fire Fighting Wear self-contaminated breathing apparatus and protective clothing 

Procedures to prevent contact with skin and ~es. 

Unusual Fire and Sealed contafners may rupture explosively if heated. Keep any driftS 

Explosion Hazards or containers cool with water spray while fight ina any fire. 

Containers that rupture explosively may autolgnite. 

Autolgnitlon Temperature 452.3'F, 233.5'C 

Section 8: Accidental Rei••• M8Murea 

Small Quantities 

Large Quantities 

Take up with an absorbent material and place Into non-leaking 

containers. Seal tightly for property disposal with other hazardous 

wastes. 

Collect the product and place Into non-leaking containers in order to 

isolate from woril:ers and environment Properly dispose by 

transportation to a permitted disposal facility for disposal as 

a hazardous waste by Incineration or landfill in compliance with federal, 

state, and local regulations. 

Do not dispose to sewers, lakes, rivers or streams. 

ti Page 4 of 1 1 

September 21 , 2006 

Acryloyl Morpholine 

p.22 22/29 
92'812757385 06:27 03 a.m. 07-24-2008 

Section 7: Handling, Storat; e. and Disposal Precautions 

Protective Clothing and 

Respirator Equipment 

Each person who Is reasonably likely to be dermally exposed to ACMO 

through direct handling of the substance or because the substance 

becomes airboma as vapor, should wear the following personal 

protective equipment that selected in accordance with 

29 CER 1910.132 through 29 CFR 1910.138. 

Also. ACMO should not be used In non-closed systems. 

(1)Gioves: 

Gloves that provides an Impervious barrier to prevent dermal 

expoaure 

·When each person Is reasonably likely to be exposed to 100%ACMO, 

gloves in the following specification should be wom. 

Material Use restriction time in hours 

Safety 414H EVOHIPE laminate : 8.0 

Ansell Edmont Neoprene 'I 865 : 6.5 

... $.o.'Y~ .. Nitrtlet . .Rutltlt.( ... ~ .. 'I.7.~ ...•... ~ ......................... ~ •. Q .......................... . 

• When eaCh person is reasonably likely to be exposed to mixtures 

containing ACMO, gloves meeting ASTM test F739-96 and F1194-89 

should be wom. Glove permeability test data must be submitted 

to EPA and approved for each new mixture that will be used 

(except for research and development) within one year after 

commencement of commercial use. 

Please contact for further information 

in glove test requirements. 

(2)Ciothing: 

Clothing which covers any other exposed areas of the arms, 

legs and torso 

(3)Respirator: 

• NIOSH approved respirator Category 23C or Category 19C Type c 

in compliance with OSHA 

t'\ 

Page 5 of 1 1 

September 21 , 2006 

Acryloyl Morpholine 
92812757385 06 27:13 a.m. 07-24-2008 

Sec tlon 7: Handling, Stor.!Mle. and Dl~osal Precautions 

Storage and Handling 

Precautions 

Waste Disposal Method 

'-' 

• Store drums inside a warehouse and where air is available. 

• Store drums at temperatures under 9 5 • F , 3 5 • c. 

·Supply water through Insulated and heat-traced lines to prevent 

freeze-up In cold weather. 

• Oo not store drums near sources of heat or fire or in direct sunlight. 

• Oo not heat drums with steam or electrical equipment. 

• Do not store drums In more than two layers and two lines in groups 

of 48 drums. Have aisle of fourteen (14) feet minimum on all sides. 

• Place into non-leaking containers and seal tightly. Transport 

the material to a permitted facility for proper disposal by incineration 

or landfill with other hazardous wastes in accordance with federal, 

state and local regulations. 

• Do not discharge this product into sewers, rivers, lakes or streams. 

N o T E : State and local regulations may be more stringent than 

federal regulations. 

?o 

Page e of 1 1 

September 21 , 2006 

Acryloyl Morpholine 

p.24 24/29 
92812757385 06.27.20 a.m. 07-24-2008 

Secf 8 Ex t UPera al P t f I On . (posure con ro on ro ec 1on 

General requirement 

'._ 

Signs and Symptoms of 

Exposure 

Precautions to Avoid 

Ingestion 

Precautions to Avoid 

Skin Contact 

Precautions to Avoid 

Eye Contact 

Precautions to Avoid 

Inhalation 

Use ACMO in enclosed equipment such as closed-top blending tanks 

and enclosed UV or EB curing equipment Any potential exposure 

should be limited to Incidental exposure during container filling and 

pouring and roll application and cleaning activities. 

Signs or symptoms of exposure include odors ancl eye, skin or 

respiratory irritation. However, exposure should be avoided even 

in the absence of signs or symptom•. 

Keep all food in area separate from storage and use locations. 

Prohibit eating, drinking and smoking in areas where there is a 

potential for significant exposure to this material. Thoroughly 

wash hands and face before eating_. 

Use impervious clothing and gloves. and footwear selected with 

regard use-condition-exposure potential. Provide an eye walh and 

an emergency safety shower in all areas where this material is 

handled or stored. See Section 7. 

Use goggles and a face shield selected with regard to usecondition-exposure potential. Provide eye-wash fountains or other means 

of washing the eyes with a genUe flow of tap water in all areas wheret 

his material Is handled or stored. 

Store and handle this material in well ventilated areas. 

NIOSH approved respirator Category 23C or Category 19C Type C 

In compliance with OSHA should be wom when workers are reasonably 

likely to be exposed. 

Page 7 of 1 1 

September 21 • 2006 

Acryloyl Morpholine 

p. 2525/29 
92812757385 

Section 9: Physical and Chemical Propertlea 

. 

,_ 

Appearance 

Odor 

Boiling Point(01 atm) 

Freezing Temperature 

Vapor Pressure(mmHg @ 25' C} 

Vapor Density 

Relative Density(04 2 0 ) 

Evaporation Rate( Butyl Acetate=1) 

Viscosity 

Solubility in Water 

Partition Coefficient 

Hygroscoprcity 

p.26 06:27 31 a.m. 07-24-2008 26/29 

clear and colorless liquid above -8' c 

Low 

471' F I 244' c 

17.6' F, -8' C 

7.73x1o-:s 

4.9 

1.1185 

0.02 

12C.I).S.(at 77' F) 

Soluble In water and other ordinary organic 

solvents. 

Log P = .0.46 at 20.5' C 

1.8g/100g(at 20' C SORH%) 

Page 8 of 1 1 

September 21 , 2006 

Aayloyl Morphollne 
p.27 

92812757385 06:27 38 a.m. 07-24-2008 27/29 

Section 10: Stability and Reactivity 

Chemical Stability This product is stable when propef'ly inhibited and stored under 95" F 

in the dartc. cool place where a gas mixture of 5-2196 oxygen exists. 

Condition to Avoid This product may become unstable when subjected to temperatures 

above 95' F ,light or polymerization catalylta. 

Do not mix with other chemieals or purge with Inert gas. 

Keep away from peroxides or other catalysts as this chemical may 

autoignite. 

Do not handle In an oxygen(alr) free atmosphere since the presence 

the oxygen is necessary for M E H Q to function effectively. 

Avoid contamination of monomer with polymerized A c M 0 that might 

be present In localized or hot stagnant areas such as dead-head 

pumps or heated transfer lines. 

Incompatibility with Peroxides and peroxide and free-radical forming compounds(such 

Other Materials as aldehydes, ethers, azides, etc)promote polymerization. 

Hazardous Decomposition No applicable Information found. 

And Byproducts 

Hazardous Polymerization Hazardous polymeriZation may occur In . when this product Is exposed 

to temperatures above 95' F, light, or polymerization catalysts such as 

peroxides and percjxide and free radical forming compounds. 

Maintain the level of ME H Q inhibitor at approximately 1,000 ppm. 

Do not use an inert atmosphere, but maintain at lent 10 % void 

volume above A c M o because the presence of alr(2196 oxygen)is 

required for the ME H Q inhibitor to be effective. 

Sect ton 11: Toxicological I n f ormation 

Oral median lethal dose (LD5 0 ) 

Dermal median lethal dose (LO 8 0 ) 

Inhalation median lethal concentratlon(LDu) 

Primary Irritation Index 

Eye Irritation 

SensitizationfOECD406, Buehler Method] 

Chronic Effect 

Toxicologically synergistic products 

588 mglkg bodywelght (rats) 

greater than 2,000 mglkg bodywelght (rats) 

!greater than 5.28 mg/1 (1 and 4hour, rats) 

0.5 (mildly irritating to rabbit skin) 

severely irritating 

No signs of skin sensitization 

No applicable information found 

No applicable information found 

Page 9 of 1 1 

September 21 , 2006 

Acryloyl Morpholine 
91812757385 

\. 

-

Sect on 11: Toxlcolog. I c al I n f ormat on 

13-week Oral toxicity [OECO 408) 

Reproduction/developmental toxicity 

screening test [OECO 422] 

Neurotoxicity screening battery 

[EPA OPPTS 870.6200] 

13-week Inhalation toxlcity[OECD 413] 

Mutagenicity(Bacteriological test) 

Mouse micronucleus test 

(Non-bacteriological test In vivo}: 

p.28 

06 27.51 a.m. 07-24-2008 28/29 

NOEL•20mglkg/day{rats) 

NOEL=75mglkglday(rats} 

NOEL=75mglkglday(rats) 

NOEL <0.0124mg/Uday(rats) 

Negative 

Negative 

Secl ton 12: E coogt I !call norm f atl on 

....__. 

The EC110 value foe" immobilization to daJ)hnia magna in water(SUCI"' as lakes, rivers, and streams) 

is 330mg/1(24hours), 120mgn(48hours). 

Concentration of this substance aboVe 120mg/l did not cause abnormalities in algal growth. 

The EC a 0 (respiration Inhibition} value for this substance with activated sewage sludge 

Is _g_raater than 100mgl1 (three-nours). 

This substance Is not readily biodegradable. 

Section 13: Transl)ort Information 

Hazard Class Not regulated for transport via IMO, ICAO 

Not regulated for transport. USA DOT 49CFR 

Packing group Not applicable 

UN/NA Not applicable 

identlfication number 

Reportable Quantity( R Q} Not applicable for transport 

Page 1 0 ofl 1 

September 21 , 2006 

Acryloyl Morpholine 
9:!'812757385 06 28:01 a.m. 07-24-2008 

s ectlon 14 . R tegu lat ory 1 norm ~ ar ton 

Toxic Substance Control ACMO is authorized for sales pursuant to a voluntary consent 

Act(TSCA) order between and the EPA. 

The EPA has issued· a significant new Ult ry~ANUR) under 

SectionM~(2)J:#Jfili.G:iAJor Aci'YIDYI Mo ··'· ..ak.~FR721.5185. 

(~clOS:i .o i1 ;;-u~ ;hiid10iMfYTIIU:J:k 

C E R C LA/Superfund This chemical substance is not listed, but see reporting 

40 C. F.R. § 117, 302 requirements for unlisb!id substances In 40 C.F.R. §§ 302.5 

and 302.6 

S A R A /Superfund This chemical substance is not listed. 

Amendments and 

Reauthorization Act of 

1988 

S A R A /Section 302- This chemical substance Is not listed in Appendix A or B as an 

Extremely Hazardous Extremely Hazardous Substance. 

Substance 40 C. F. R. §355 

SA RA/Sectlon 311 This chemical substance Is not listed, but see the reporting 

and 312· 40 requirements In 40 C.F.R. §370.21 for reporting each hazardous 

C. F.R. § 370 chemical for which in MSOS Is required by OSHA. 

SARA /Section 313· This chemical substance is not listed. 

LIST OF Toxic Chemicals 

40 C. F.R. 372 

The information in this Material Safety Data Sheet relates specifically to the product designated and 

may not be valid for the product when used with other materials or particular processes. 

While believes the data set forth herein are accurate. 

makes no warranty with respect to thereto and expressly disclaims 

all liability for reliance thereon. Such data are offered solely for your consideration Investigation, and 

verification. It is the user's responsibility to determine the suitability of any material for a specific use 

and to adopt safety precautions as may be necessary. 

Page 1 1 of 1 1 

September 21 , 2006 

Acryloyl Morpholine 

p.29 29/29